R01ES037626
Project Grant
Overview
Grant Description
NICKEL EXPOSURE DISRUPTS SP1/ZEB1-DEPENDENT TRANSCRIPTIONAL REGULATION - PROJECT SUMMARY NICKEL (NI) COMPOUNDS ARE OCCUPATIONAL AND ENVIRONMENTAL TOXICANTS. ALTHOUGH NI OCCURS NATURALLY, INDUSTRIAL PROCESSES INCLUDING FOOD PROCESSING, MINING, AND REFINING, AS WELL AS EXTENSIVE USE OF NI-CONTAINING PRODUCTS (E.G., STAINLESS STEEL, BATTERIES, AND MEDICAL DEVICES) HAVE SIGNIFICANTLY INCREASED ITS LEVELS IN THE ENVIRONMENT. NI EXPOSURE IS ASSOCIATED WITH CHRONIC INFLAMMATORY LUNG DISEASES SUCH AS ASTHMA, FIBROSIS, BRONCHITIS, EMPHYSEMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). EXPOSURE TO ENVIRONMENTAL LEVELS OF NI HAS BEEN ASSOCIATED WITH DECREASED PULMONARY FUNCTION, AND AMBIENT NI EXPOSURE IN CHILDREN HAS BEEN SHOWN TO CAUSE ALVEOLAR INFLAMMATION. AN ASSOCIATION BETWEEN BLOOD NI CONCENTRATIONS AND DECREASED LUNG FUNCTION HAS ALSO BEEN IDENTIFIED RECENTLY. MOREOVER, EPIDEMIOLOGICAL STUDIES SHOW THAT NI EXPOSURE IS ASSOCIATED WITH LUNG AND NASAL CANCERS. HOWEVER, THE MOLECULAR BASIS OF NI-INDUCED DISEASES REMAINS POORLY UNDERSTOOD. THE OVERARCHING GOAL OF THIS GRANT IS TO UNCOVER THE MECHANISMS UNDERLYING NI EXPOSURE-ASSOCIATED LUNG DISEASES. OUR PRELIMINARY RESULTS SHOW THAT NI EXPOSURE CAUSED GENE SILENCING, WHICH PERSISTED EVEN AFTER THE TERMINATION OF EXPOSURE. NOTABLY, WE FOUND PERSISTENT DOWNREGULATION OF THE GENES INVOLVED IN CELL ADHESION AND EXTRACELLULAR MATRIX ORGANIZATION, INCLUDING E-CADHERIN (CDH1), LEADING TO EPITHELIAL-MESENCHYMAL TRANSITION (EMT), A KEY PROCESS IN NI-INDUCED LUNG DISEASES MENTIONED ABOVE. OUR RESULTS ALSO REVEALED PERSISTENT DOWNREGULATION OF MANY TUMOR SUPPRESSOR GENES FOLLOWING NI EXPOSURE. THESE RESULTS SUGGEST THAT NI-INDUCED GENE SILENCING PLAYS A SIGNIFICANT ROLE IN DISEASE PATHOGENESIS. OUR INVESTIGATION OF THE PERSISTENTLY DOWNREGULATED CDH1 GENE SUGGESTED DISPLACEMENT OF SP1, A TRANSCRIPTIONAL ACTIVATOR, FROM ITS PROMOTER AS KEY FOR ITS NI-INDUCED SILENCING. INTERESTINGLY, SP1 DISPLACEMENT WAS ACCOMPANIED BY RECRUITMENT OF ZEB1, A TRANSCRIPTIONAL REPRESSOR, TO THE SAME LOCUS. MOREOVER, WE ALSO FOUND COLOCALIZATION OF SP1 AND ZEB1 BINDINGSEQUENCES AT HUNDREDS OF NI-DOWNREGULATED GENE PROMOTERS. THIS SUGGESTS THAT SP1 AND ZEB1 BINDING CONSTITUTE A GENE REGULATORY SWITCH, WHICH IS DISRUPTED BY NI EXPOSURE. SP1 AND ZEB1 ARE WELL-KNOWN CHROMATIN MODIFIERS. BASED ON OUR PRELIMINARY RESULTS, WE HYPOTHESIZE THAT NI EXPOSURE DISRUPTS THE SP1- ZEB1 GENE REGULATORY SWITCH, ALTERING THE EPIGENOMIC LANDSCAPE AND RESULTING IN ABERRANT GENE SILENCING. IN AIM 1, WE WILL CHARACTERIZE THE NI-INDUCED ALTERATIONS TO SP1-BINDING ACROSS THE GENOME AND THE RESULTANT CHANGES TO THE EPIGENOMIC LANDSCAPE. IN AIM 2, WE WILL INVESTIGATE THE ROLE OF ZEB1 IN NI-INDUCED PERSISTENT GENE SILENCING. IN AIM 3, WE WILL EXAMINE THE CONSEQUENCES OF NI-INDUCED DISRUPTION OF SP1-ZEB1 REGULATORY SWITCH IN VIVO. THE OVERALL IMPACT OF OUR STUDY WILL BE A COMPREHENSIVE UNDERSTANDING OF THE MECHANISMS UNDERLYING NI-INDUCED LUNG DISEASES.
Awardee
Funding Goals
<P>THE GOALS ARE:</P><UL><LI>TO FOSTER FUNDAMENTAL CREATIVE DISCOVERIES, INNOVATIVE RESEARCH STRATEGIES, AND THEIR APPLICATIONS AS A BASIS FOR ULTIMATELY PROTECTING AND IMPROVING HEALTH;</LI><LI>TO DEVELOP, MAINTAIN, AND RENEW SCIENTIFIC HUMAN AND PHYSICAL RESOURCES THAT WILL ENSURE THE NATION'S CAPABILITY TO PREVENT DISEASE;</LI><LI>TO EXPAND THE KNOWLEDGE BASE IN MEDICAL AND ASSOCIATED SCIENCES IN ORDER TO ENHANCE THE NATION'S ECONOMIC WELL-BEING AND ENSURE A CONTINUED HIGH RETURN ON THE PUBLIC INVESTMENT IN RESEARCH; AND</LI><LI>TO EXEMPLIFY AND PROMOTE THE HIGHEST LEVEL OF SCIENTIFIC INTEGRITY, PUBLIC ACCOUNTABILITY, AND SOCIAL RESPONSIBILITY IN THE CONDUCT OF SCIENCE.</LI></UL><P>IN REALIZING THESE GOALS, THE NIH PROVIDES LEADERSHIP AND DIRECTION TO PROGRAMS DESIGNED TO IMPROVE THE HEALTH OF THE NATION BY CONDUCTING AND SUPPORTING RESEARCH:</P><UL><LI>IN THE CAUSES, DIAGNOSIS, PREVENTION, AND CURE OF HUMAN DISEASES;</LI><LI>IN THE PROCESSES OF HUMAN GROWTH AND DEVELOPMENT;</LI><LI>IN THE BIOLOGICAL EFFECTS OF ENVIRONMENTAL CONTAMINANTS;</LI><LI>IN THE UNDERSTANDING OF MENTAL, ADDICTIVE AND PHYSICAL DISORDERS; AND</LI><LI>IN DIRECTING PROGRAMS FOR THE COLLECTION, DISSEMINATION, AND EXCHANGE OF INFORMATION IN MEDICINE AND HEALTH, INCLUDING THE DEVELOPMENT AND SUPPORT OF MEDICAL LIBRARIES AND THE TRAINING OF MEDICAL LIBRARIANS AND OTHER HEALTH INFORMATION SPECIALISTS.</LI></UL>
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100102533
United States
Geographic Scope
Single Zip Code
Related Opportunity
New York University was awarded
Nickel Exposure Effects on Lung Disease Gene Regulation
Project Grant R01ES037626
worth $3,234,310
from the National Institute of Environmental Health Sciences in June 2026 with work to be completed primarily in New York New York United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.113 Environmental Health.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 7/6/26
Period of Performance
6/20/26
Start Date
6/19/30
End Date
Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
R01ES037626
SAI Number
R01ES037626-3419094072
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NV00 NIH National Institute of Enviromental Health Sciences
Funding Office
75NV00 NIH National Institute of Enviromental Health Sciences
Awardee UEI
M5SZJ6VHUHN8
Awardee CAGE
3D476
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Modified: 7/6/26